company background image
MKD

Molecular DataNasdaqCM:MKD Stock Report

Market Cap

US$43.0m

7D

-15.3%

1Y

-78.4%

Updated

28 Nov, 2021

Data

Company Financials +
MKD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

MKD Stock Overview

Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People’s Republic of China.

Price History & Performance

Summary of all time highs, changes and price drops for Molecular Data
Historical stock prices
Current Share PriceUS$0.25
52 Week HighUS$2.23
52 Week LowUS$0.18
Beta0
1 Month Change-33.55%
3 Month Change-38.42%
1 Year Change-78.45%
3 Year Changen/a
5 Year Changen/a
Change since IPO-95.42%

Recent News & Updates

Shareholder Returns

MKDUS Online RetailUS Market
7D-15.3%-5.1%-2.7%
1Y-78.4%-11.3%21.3%

Return vs Industry: MKD underperformed the US Online Retail industry which returned -11.3% over the past year.

Return vs Market: MKD underperformed the US Market which returned 21.3% over the past year.

Price Volatility

Is MKD's price volatile compared to industry and market?
MKD volatility
MKD Average Weekly Movement17.5%
Online Retail Industry Average Movement8.9%
Market Average Movement6.0%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.3%

Stable Share Price: MKD is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 18% a week.

Volatility Over Time: MKD's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
2013189Steven Foohttps://www.molbase.cn

Molecular Data Inc., through its subsidiaries, operates in the chemical e-commerce business in the People’s Republic of China. The company operates technology-driven platform that connects participants along the chemical value chain through its integrated solutions. It delivers e-commerce solutions, financial solutions, warehousing and logistics solutions, and software-as-a-service suites for participants in the traditional chemical industry.

Molecular Data Fundamentals Summary

How do Molecular Data's earnings and revenue compare to its market cap?
MKD fundamental statistics
Market CapCN¥274.74m
Earnings (TTM)-CN¥255.83m
Revenue (TTM)CN¥4.62b

0.1x

P/S Ratio

-1.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
MKD income statement (TTM)
RevenueCN¥4.62b
Cost of RevenueCN¥4.62b
Gross Profit-CN¥2.68m
ExpensesCN¥253.15m
Earnings-CN¥255.83m

Last Reported Earnings

Jun 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-1.49
Gross Margin-0.057%
Net Profit Margin-5.54%
Debt/Equity Ratio-137.3%

How did MKD perform over the long term?

See historical performance and comparison

Valuation

Is Molecular Data undervalued compared to its fair value and its price relative to the market?


In this section, we usually try to help investors determine whether Molecular Data is trading at an attractive price based on the cash flow it is expected to produce in the future. But as Molecular Data has not provided consistent financial data, and the stock also has no analyst forecast or coverage, its intrinsic value cannot be reliably calculated by extrapolating past data or using analyst consensus cash flow predictions.

This is quite a rare situation as 89% of companies covered by Simply Wall St do have a valuation analysis.


Future Growth

How is Molecular Data forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

31.2%

Forecasted Retail industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Molecular Data has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has Molecular Data performed over the past 5 years?

-17.1%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: MKD is currently unprofitable.

Growing Profit Margin: MKD is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: MKD is unprofitable, and losses have increased over the past 5 years at a rate of 17.1% per year.

Accelerating Growth: Unable to compare MKD's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: MKD is unprofitable, making it difficult to compare its past year earnings growth to the Online Retail industry (79.3%).


Return on Equity

High ROE: MKD's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Financial Health

How is Molecular Data's financial position?


Financial Position Analysis

Short Term Liabilities: MKD has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: MKD has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: MKD has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: MKD's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Insufficient data to determine if MKD has enough cash runway based on its current free cash flow.

Forecast Cash Runway: Insufficient data to determine if MKD has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.


Dividend

What is Molecular Data current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate MKD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate MKD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if MKD's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if MKD's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of MKD's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.9yrs

Average board tenure


CEO

Steven Foo (49 yo)

0.50

Tenure

Mr. Steven Foo serves as the Chief Financial Officer at Molecular Data Inc. since December 01, 2020 and serves as its Chief Executive Officer since May 14, 2021. Mr. Foo had been Executive Director of Chin...


Board Members

Experienced Board: MKD's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 32.6%.


Top Shareholders

Company Information

Molecular Data Inc.'s employee growth, exchange listings and data sources


Key Information

  • Name: Molecular Data Inc.
  • Ticker: MKD
  • Exchange: NasdaqCM
  • Founded: 2013
  • Industry: Internet and Direct Marketing Retail
  • Sector: Retail
  • Market Cap: US$42.983m
  • Shares outstanding: 171.93m
  • Website: https://www.molbase.cn

Number of Employees


Location

  • Molecular Data Inc.
  • Building 15
  • 11th Floor
  • Shanghai
  • 201106
  • China

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/28 23:18
End of Day Share Price2021/11/26 00:00
Earnings2021/06/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.